MedTrace Logo

The Use of the UroShield Device in Patients With Indwelling Urinary Catheters

NCT00446732 · Status: UNKNOWN · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2009-03-25

No results posted yet for this study

Summary

According to the Israeli Ministry of Health requirement, this study was designed to evaluate the efficacy of the UroShield system is patients that require urinary catheterization. This was designed to compare standard treatment (urinary catheter alone) with the UroShield treatment in occurrence of catheter associated Urinary Tract infection, pain, discomfort, Biofilm prevention and trauma.

Conditions

Interventions

DEVICE

UroSshield

Attachment of the UroShield device to the external part of the urinary catheter

Sponsors & Collaborators

  • Shaare Zedek Medical Center

    collaborator OTHER

  • Nanovibronix

    lead INDUSTRY

Principal Investigators

  • Ofer Shenfeled, MD · Sharei Zedek

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-03-31
Primary Completion
2009-04-30
Completion
2009-06-30

Countries

  • Israel

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00446732 on ClinicalTrials.gov